It’s clear that Bayer AG has a first-in-class OTC allergy product it plans to launch in the US in 2022. What’s not clear is whether Astepro Allergy’s boost to the firm’s consumer health business sales will be enhanced by market exclusivity.
The German firm’s Bayer Healthcare LLC business in Whippany, NJ, has labeling approved for eight separate packaging configurations of the...







